Best GLP-1 Medications

Understanding GLP-1 Weight Loss Medications

GLP-1 medications have become some of the most talked-about treatments in modern weight management — and the interest is justified. Unlike older “diet pills” that relied on stimulants or blocked fat absorption, GLP-1 receptor agonists work with the body’s own hormonal systems to regulate hunger, fullness, and blood sugar.

Most GLP-1 medications are given as a once-weekly subcutaneous injection using a prefilled pen with a small, fine needle. The process is quick, self-administered at home, and for many patients less intimidating than it sounds. Oral formulations also exist — Rybelsus® (oral semaglutide) for type 2 diabetes, and more recently an oral Wegovy® and Foundayo™ (orforglipron) approved for chronic weight management.³

How GLP-1 medications work?

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases naturally after you eat. It signals fullness to the brain, slows how quickly food leaves the stomach, and helps regulate the release of insulin. GLP-1 medications are designed to mimic that hormone — extending and amplifying those natural signals.

The result, in clinical studies, is a reduction in appetite, smaller portion sizes, improved blood-sugar control, and — for many patients — significant, sustained weight loss when combined with nutrition and lifestyle changes.⁴

Tirzepatide (the active ingredient in Zepbound® and Mounjaro®) takes this further by activating a second receptor, GIP (glucose-dependent insulinotropic polypeptide). That dual mechanism has produced the largest average weight reductions of any currently FDA-approved GLP-1 medication.⁵

GLP-1 medications are not a magic bullet. They are most effective when combined with adequate nutrition, regular movement, sleep, and stress management. They also don’t work the same way for everyone — response to GLP-1 therapy varies meaningfully between individuals, and some people will not be appropriate candidates based on their medical history.

How to Access GLP-1 Treatment Safely Online

Telehealth has made GLP-1 prescriptions more accessible than ever — a licensed provider can now evaluate your eligibility, prescribe treatment when appropriate, and arrange home delivery, all without leaving the couch. But convenience cuts both ways. Not every online service that advertises GLP-1 medications is operating responsibly, and the gap between legitimate telehealth and questionable operations is wider than most patients realize.

Here is what to look for when evaluating an online GLP-1 provider:

Licensed U.S. clinicians. Every provider featured on this page works with clinicians who hold state licenses in the states where they prescribe. You can verify any clinician’s license through their state medical board’s public lookup tool. A legitimate telehealth service will be transparent about the clinicians who practice on its platform.

Licensed pharmacies. Prescriptions should be filled by U.S.-based pharmacies licensed in your state. For compounded medications, this means a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility. For brand-name medications like Zepbound® and Wegovy®, dispensing happens through a retail or mail-order pharmacy that stocks the manufacturer’s product.

NABP verification. The National Association of Boards of Pharmacy (NABP) maintains a public list of verified online pharmacies at safe.pharmacy. Providers that work with NABP-verified pharmacies are operating within a recognized regulatory framework.

A real medical intake — not a sales funnel. A legitimate provider will ask detailed questions about your medical history, current medications, allergies, and weight-related conditions before issuing a prescription. If a service promises a guaranteed prescription, skips meaningful clinical review, or ships medication the same day you sign up without a genuine health evaluation, treat that as a warning sign.

Clear product labeling. Medications you receive should arrive with proper labeling — including the drug name, dosage, lot number, and expiration date. Brand-name medications will include the manufacturer’s packaging. Compounded medications should include the compounding pharmacy’s information.

Transparent pricing. Quality providers publish their pricing clearly — monthly medication cost, consultation fees if any, and what is and isn’t included. If you can’t find pricing without first handing over payment information or personal health data, that’s worth pausing on.

If an offer seems significantly cheaper than anything else in the market, bypasses medical consultation, or ships from overseas, be cautious. Genuine FDA-approved GLP-1 medications are expensive to produce, and legitimate compounded versions require licensed pharmacy infrastructure — neither can be delivered at prices that undercut the market by 80%.

Popular GLP-1 Weight Loss Medications

If you’ve been researching GLP-1 treatments, four FDA-approved medications dominate the conversation. Here is what distinguishes each.

Wegovy® (Semaglutide)

Wegovy® was approved by the FDA in June 2021 as the first once-weekly GLP-1 medication indicated specifically for chronic weight management.⁶ Manufactured by Novo Nordisk, it’s prescribed for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol).

In the STEP-1 clinical trial, adults taking weekly 2.4 mg semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared with 2.4% in the placebo group.² Wegovy® was also approved in 2024 to reduce the risk of major cardiovascular events (heart attack and stroke) in adults with established cardiovascular disease and overweight or obesity — making it the first weight-management medication with a cardiovascular-benefit indication.

Wegovy® is administered as a weekly subcutaneous injection, with dosing titrated upward over approximately 16 weeks to the maintenance dose. An oral Wegovy® formulation has also been approved, offering a daily pill alternative for patients who prefer to avoid injections.

Zepbound® (Tirzepatide)

Zepbound®, manufactured by Eli Lilly, was approved by the FDA in November 2023 for chronic weight management in adults.⁷ It was later approved for moderate-to-severe obstructive sleep apnea in adults with obesity — the first medication with that specific indication.

Zepbound® is distinguished by its dual mechanism. Unlike other FDA-approved GLP-1 medications, tirzepatide activates both the GLP-1 and GIP receptors. This dual action has produced the largest average weight reductions seen in major weight-management trials to date.

In the SURMOUNT-1 trial, adults taking the highest dose (15 mg) lost an average of 20.9% of their body weight over 72 weeks — approximately 48 pounds for a typical participant.⁵ In SURMOUNT-5, a head-to-head comparison against semaglutide, tirzepatide produced an average 20.2% body-weight reduction versus 13.7% for semaglutide at their respective maximum doses.¹

Zepbound® is delivered as a weekly subcutaneous injection. Tirzepatide is also sold as Mounjaro® — the same active ingredient, FDA-approved for type 2 diabetes rather than weight management.

Ozempic® (Semaglutide)

Ozempic®, also from Novo Nordisk, shares its active ingredient — semaglutide — with Wegovy®. But Ozempic® is not FDA-approved for weight loss. It is approved for managing blood sugar in adults with type 2 diabetes and for reducing cardiovascular risk in that population.⁸

So why does Ozempic® come up in weight-loss conversations? Patients using it for diabetes management frequently experienced significant weight loss as a secondary effect. That led to widespread off-label prescribing for weight management, which in turn drove Novo Nordisk to develop Wegovy® — the same molecule, dosed and labeled specifically for chronic weight management.

If your primary goal is weight loss, the FDA-approved semaglutide option is Wegovy®, not Ozempic®. Ozempic® remains the appropriate choice for patients managing type 2 diabetes.

Saxenda® (Liraglutide)

Saxenda® was the first GLP-1 medication approved by the FDA for chronic weight management, in December 2014.⁹ Its active ingredient, liraglutide, is administered as a daily — rather than weekly — injection, which some patients find less convenient but others prefer for its faster titration schedule.

In the SCALE clinical trial, adults taking 3.0 mg liraglutide lost an average of 8% of their body weight over 56 weeks, compared with 2.6% on placebo.¹⁰ These results are more modest than the newer weekly GLP-1 medications, but Saxenda® remains a clinically established option — particularly for adolescents aged 12–17 with obesity, for whom it received an expanded FDA indication in 2020.

Generic liraglutide is now also available, which has lowered the cost of this option compared with the original Saxenda® branding.

Compounded vs. Brand-Name GLP-1 Medications

Many of the telehealth providers featured above offer compounded GLP-1 medications — custom-prepared formulations made by state-licensed compounding pharmacies, containing the same molecule class as the brand-name products. Understanding the distinction is important.

Brand-name GLP-1 medications — including Wegovy®, Zepbound®, Ozempic®, Mounjaro®, Saxenda®, and Rybelsus® — have completed the full FDA approval process. Their safety, efficacy, manufacturing quality, and dosing have been formally reviewed by the agency, and they are manufactured under strict oversight.

Compounded GLP-1 medications are prepared by state-licensed compounding pharmacies. Compounding plays a legitimate role in medicine — for example, when a patient has a specific allergy, needs a modified dose, or when a commercial product is temporarily unavailable. However:

• Compounded drugs are not FDA-approved.
• The FDA does not evaluate them for safety, effectiveness, or quality.
• They may differ from the brand-name product in formulation, potency, or delivery format (including non-FDA-approved formats like oral tablets or sublingual drops).
• Regulatory status of mass-market compounded GLP-1s has shifted significantly since 2024, and continues to evolve.

Some patients choose compounded options for cost or accessibility reasons; others prioritize FDA-approved brand-name medications for the added regulatory assurance. There is no single “right” answer — but the decision should be made with a licensed clinician who understands your individual circumstances, not based on advertising alone.

How to Choose a Trusted GLP-1 Provider

Once you’ve narrowed down to a few legitimate telehealth platforms, the deeper question is care quality. A prescription is only one piece of a comprehensive weight-management plan, and the difference between providers often lies in what happens around the medication.

Comprehensive intake and baseline labs. A quality provider evaluates your whole health picture before prescribing — not just your BMI. That typically includes reviewing your medical history, current medications, and a baseline lab panel that may cover HbA1c, fasting insulin, thyroid function, liver enzymes, and lipid panel. Unaddressed issues (like untreated thyroid dysfunction or insulin resistance) can limit your response to GLP-1 therapy.

Ongoing medical supervision. GLP-1 medications have significant metabolic effects. As you lose weight, your body may require adjustments to other medications — notably diabetes treatments, blood pressure medications, and thyroid therapy. A quality provider monitors your progress, checks in on side effects, and adjusts your plan as your body changes.

Nutritional support. Because GLP-1 medications reduce appetite significantly, patients sometimes under-consume protein or key micronutrients — which can lead to loss of lean muscle mass or fatigue. Providers that include registered dietitians or structured nutrition guidance help patients maintain adequate nutrition while reducing overall intake. Protein, fiber, healthy fats, and hydration are especially important during active weight loss.

Behavioral and lifestyle coaching. Medication works best alongside durable changes in how you eat, move, sleep, and manage stress. Providers that offer coaching, habit-building tools, or mental-health support tend to produce more sustainable outcomes than medication-only programs.

Side-effect management. Most patients experience some gastrointestinal side effects — nausea, constipation, or indigestion — particularly during dose escalation. A responsive provider will help you manage these through dose timing, diet adjustments, and supportive care rather than leaving you to figure it out alone.

Transparent medication sourcing. Your medication should come with clear labeling including NDC (National Drug Code) numbers for brand-name products, or lot numbers and compounding pharmacy identification for compounded products. This allows traceability back to a licensed source.

The gold standard of care is a provider that screens you thoroughly, establishes a baseline, starts you at a low dose with gradual titration, provides ongoing follow-up and nutritional guidance, and sources medication from state-licensed pharmacies. Taking the time to find this level of care is one of the most consequential choices you’ll make.